CFDE Data Portal | Search SNX2P1

	Label	Description
	SNX2P1 Gene (Entity type)	ENSG00000270585 - sorting nexin 2 pseudogene 1
	GSE111247 temozolomide LN-308 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE138057 p53 HDAC8 inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Breast 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pancreas 20-29 vs 60-69 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pancreas 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE107932 TRIM52 knockdown U-87MG Uppsala 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

SNX2P1

ENSG00000270585 - sorting nexin 2 pseudogene 1

GSE111247 temozolomide LN-308 0 v 8 human up

A Gene Set from LINCS

GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 3 v 0 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE138057 p53 HDAC8 inhibition 0 v 1 human up

A Gene Set from LINCS

GTEx Breast 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Breast 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx Pancreas 20-29 vs 60-69 Down

A Gene Set from GTEx

GTEx Pancreas 20-29 vs 40-49 Down

A Gene Set from GTEx

GSE107932 TRIM52 knockdown U-87MG Uppsala 0 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.